Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-009070

Chief Executive Officer acquired 28,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kauffman Michael · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-05 Exercise or conversion : show line 1 in the form +14,300 569,422 D
2021-02-05 Exercise or conversion : show line 2 in the form +14,300 770,789 I

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2021-02-05 Exercise or conversion : show line 3 in the form Restricted Stock Units −14,300 14,300 42,900 D
2021-02-05 Exercise or conversion : show line 4 in the form Restricted Stock Units −14,300 14,300 42,900 I
Loading xslF345X03/doc4.xml…